SES Successfully Prices EUR 1 Billion Hybrid Dual-tranche Bond Offering
NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE UNITED STATES), OR TO ANY US PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933), OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.
SES S.A. announced the successful launch and pricing of a hybrid dual-tranche bond offering in which it has agreed to sell Deeply Subordinated Fixed Rate Resettable Securities for a total amount of EUR 1 billion.
The transaction is composed of a EUR 500 million 30-year Non-Call (NC) 5.25-year tranche with a first reset date on 12 December 2029 and a EUR 500 million 30-year NC 8-year tranche with a first reset date on 12 September 2032. The NC 5.25-year notes will bear a coupon of 5.5% per annum and were priced at 99.473% of their nominal value while the NC 8-year notes will bear a coupon of 6% per annum and were priced at par.
The successful outcome was the result of strong investor engagement and demand as evidenced by a sizeable order book which peaked above EUR 4 billion in total and allowed SES to price the notes competitively on both tranches.
The instrument’s credit ratings are expected to be Ba2 and BB+ with Moody’s and Fitch respectively and will also rank pari-passu with SES outstanding EUR 625 million Deeply Subordinated Fixed Rate Resettable Securities, with a first reset date on 27 August 2026. The new hybrid bonds issued by SES are non-dilutive instruments that are expected to receive 50% equity credit by both rating agencies and be classified as financial liabilities under IFRS.
The settlement is scheduled for 12 September 2024 and application has been made for the notes to be listed on the Luxembourg Stock Exchange. The securities were placed with a broad range of institutional investors across Europe.
Proceeds of the issuance will be used for general corporate purposes, including financing the acquisition of Intelsat and/or refinancing any existing indebtedness of the Group.
Sandeep Jalan, Chief Financial Officer of SES, commented, “We are pleased to have secured this new hybrid offering. The success of this transaction demonstrates investors' confidence in SES’s investment grade credit and strong cash-generation profile.”
Deutsche Bank and Morgan Stanley acted as Global Coordinators, together with BNP Paribas, Citi, HSBC and SMBC as Joint Bookrunners.
Follow us on:
Twitter | Facebook | YouTube | LinkedIn | Instagram
About SES
SES has a bold vision to deliver amazing experiences everywhere on Earth by distributing the highest quality video content and providing seamless data connectivity services around the world. As a provider of global content and connectivity solutions, SES owns and operates a geosynchronous orbit fleet and medium earth orbit (GEO-MEO) constellation of satellites, offering a combination of global coverage and high performance services. By using its intelligent, cloud-enabled network, SES delivers high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners around the world. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905028456/en/
Contacts
Richard Whiteing
Investor Relations
Tel. +352 710 725 261
richard.whiteing@ses.com
Suzanne Ong
Communications
Tel. +352 710 725 500
suzanne.ong@ses.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Gcore Introduces AI-Driven Web Application and API Protection at the Edge17.9.2024 10:00:00 CEST | Press release
Gcore, the global edge AI, cloud, network, and security solutions provider, today announced the launch of Gcore WAAP, its end-to-end web application and API protection solution. Leveraging advanced AI capabilities, Gcore WAAP integrates four powerful products in one solution: web application firewall (WAF), application-layer DDoS protection, bot management, and API security, all managed through an intuitive user interface. This comprehensive, multi-layered security solution protects digital assets across a wide range of verticals, including retail, financial services, healthcare, public sector, media and entertainment, and technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240917971916/en/ Gcore WAAP delivers comprehensive web application and API protection against a broad range of advanced threats (Graphic: Business Wire) Gcore WAAP was developed following the company’s acquisition of the StackPath WAAP solution ear
Enzian Pharmaceutics Develops a Novel Dosage Form for Enhanced Efficacy and Reduced Side Effects of Cancer Therapies17.9.2024 09:21:00 CEST | Press release
At present, the prevalent oral solid dosage forms, the capsules and tablets, are loose or lightly compacted mixtures of drug and excipient particles. Upon ingestion, they rapidly disintegrate into their constituents in the stomach. The small drug particles then are swept out of the stomach and pass through the intestine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240917927016/en/ Dr. Aron Blaesi, inventor of expandable, gastroretentive fibrous dosage forms presenting dosage forms before and after expansion due to water absorption. (Photo: Business Wire) Many kinds of cancer drug, however, are absorbed only in the acidic upper part of the gastrointestinal tract. Because the gastric residence time of the drug particles (~2-3 hours) is much shorter than the convenient dosing interval (~12-24 hours), upon repeated dosing of such drugs the drug concentration in blood fluctuates greatly. This is therapeutically not optimal: Th
Alter Domus Announces Outsourcing Partnership with Partners Group17.9.2024 09:00:00 CEST | Press release
Alter Domus, a leading provider of tech-enabled fund administration, asset and corporate services for the alternative investment industry, has entered an outsourcing partnership with Partners Group, one of the largest firms in the global private markets industry. The partnership sees Alter Domus support a broad range of operational functions for Partners Group's closed-end product offerings, spanning investment structures across the U.S., Europe and Asia. Alter Domus was selected by Partners Group for its service delivery, breadth of technology capabilities, global footprint, and the distinctiveness of its tried-and-tested approach, focused on ‘co-creating’ bespoke operating models tailored to meet the specific priorities of individual investment managers. The partnership, which went live on June 1, commits Alter Domus to invest in innovation and integration to deliver a high level of service quality and enhanced efficiency across Partners Group’s operations. Other factors include join
CSG and Cellusys Drive New Era of Innovation in Roaming17.9.2024 08:30:00 CEST | Press release
Mobile operators face growing challenges in managing complex roaming agreements, settlements and network quality, impacting their customer experience and business growth. Today,CSG® (NASDAQ: CSGS) announced a new partnership with Cellusys, the industry leader in roaming steering, fraud and security and analytics solutions for mobile operators, that will address these pain points and boost innovation in the global roaming landscape. “In any rapidly evolving industry, businesses need best-of-breed solutions that can promote their growth to stay ahead of the curve,” said Finn Kornbo, Executive Product Director, Digital Wholesale, CSG. “That's why we're partnering with Cellusys to combine our expertise and make it easy for mobile operators to optimize their roaming workflows, improve customer satisfaction and capitalize on emerging technologies like 5G and IoT.” This partnership leverages the strengths of both CSG and Cellusys to deliver a unified solution portfolio that streamlines the ro
MDPI Elevates Peer Review with AI and Innovative Technology17.9.2024 08:00:00 CEST | Press release
MDPI, a leading open access (OA) publisher, is pleased to announce its participation in Peer Review Week 2024, taking place 23–27 September. This year’s theme, “Innovation and Technology in Peer Review”, explores the evolving publishing landscape and how peer review processes shape scholarly communication. Over the week, MDPI will host online webinars from both Europe and Asia-Pacific, deliver in-person events in China, and publish new blog articles, engaging authors, reviewers, editors, and the global scientific community in the future of research integrity. Webinar: Roundtable Discussion on Innovation and Technology in Peer Review Join us as our panellists share their experiences and insights into the future of publishing, and the essential role of peer review—24 September 2024, 03:00 pm (CEST). MDPI Tools: Innovating Peer Review At MDPI, we actively pursue innovative technologies to ensure high-quality manuscripts are published in our journals. Ethicality, currently in testing,will
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom